GlassScriptPhysician profile
Kimberly W Collins
NPI 1528037348
$1,022.24
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $175 · 2021: $270 · 2022: $411.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.78 | 2019-2022 | |
| Myovant Sciences INC. | $138.92 | 2021-2022 | |
| Daiichi Sankyo INC. | $91.18 | 2019-2020 | |
| Aspira Women'S Health INC | $63.77 | 2022 | |
| Channel Medsystems, INC. | $46.48 | 2022 | |
| Mayne Pharma Commercial LLC | $41.13 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.54 | 2022 | |
| Exeltis, USA INC. | $39.65 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $34.81 | 2019 | |
| Roche Diagnostics Corporation | $27.32 | 2019 | |
| Agile Therapeutics, INC. | $18.28 | 2021 | |
| Astellas Pharma US INC | $16.66 | 2022 | |
| Covidien LP | $15.62 | 2019 | |
| Duchesnay USA Incorporated | $15.60 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.90 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.